In addition to its well-described non-metabolic molecular mechanisms responsible for tumor progression, CD147 is recently recognized as a key factor in glucose metabolism reprogramming of tumors, resulting in a competition for nutrients between tumor cells and TILs in the TME [64]. This evidence concerns the gene BSG and neoplasm.